DK0538496T3 - Rekombinant fjerkrækoppevirus med intakt FPV tk-gen - Google Patents
Rekombinant fjerkrækoppevirus med intakt FPV tk-genInfo
- Publication number
- DK0538496T3 DK0538496T3 DK91114300T DK91114300T DK0538496T3 DK 0538496 T3 DK0538496 T3 DK 0538496T3 DK 91114300 T DK91114300 T DK 91114300T DK 91114300 T DK91114300 T DK 91114300T DK 0538496 T3 DK0538496 T3 DK 0538496T3
- Authority
- DK
- Denmark
- Prior art keywords
- fpv
- gene
- intergenic region
- intact
- recombinant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91114300A EP0538496B1 (en) | 1991-08-26 | 1991-08-26 | Recombinant fowlpox virus with intact FPV-tk-gene |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0538496T3 true DK0538496T3 (da) | 2004-02-23 |
Family
ID=8207076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91114300T DK0538496T3 (da) | 1991-08-26 | 1991-08-26 | Rekombinant fjerkrækoppevirus med intakt FPV tk-gen |
Country Status (12)
Country | Link |
---|---|
US (1) | US5670367A (ja) |
EP (2) | EP0538496B1 (ja) |
JP (1) | JP2703853B2 (ja) |
AT (1) | ATE253123T1 (ja) |
AU (1) | AU661488B2 (ja) |
CA (1) | CA2076903A1 (ja) |
CZ (1) | CZ264092A3 (ja) |
DE (1) | DE69133333T2 (ja) |
DK (1) | DK0538496T3 (ja) |
ES (1) | ES2212795T3 (ja) |
HU (1) | HU9202753D0 (ja) |
SK (1) | SK264092A3 (ja) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5955652A (en) * | 1992-06-16 | 1999-09-21 | The Trustees Of The University Of Pennsylvania | Plant genes for sensitivity to ethylene and pathogens |
US6136318A (en) * | 1993-02-26 | 2000-10-24 | Cochran; Mark D. | Recombinant fowlpox viruses and uses thereof |
AU696247B2 (en) * | 1993-02-26 | 1998-09-03 | Syntro Corporation | Recombinant fowlpox viruses and uses thereof |
US5925358A (en) * | 1993-02-26 | 1999-07-20 | Syntro Corporation | Recombinant fowlpox viruses and uses thereof |
US5821059A (en) * | 1993-08-06 | 1998-10-13 | Iowa State University Research Foundation, Inc. | Mycoplasma expression system |
EP0758397B1 (en) * | 1994-04-29 | 2005-06-22 | Baxter Healthcare S.A. | Recombinant poxviruses with foreign polynucleotides in essential regions |
EP0753581A1 (en) | 1995-07-10 | 1997-01-15 | Immuno Ag | Improved recombinant eukaryotic cytoplasmic viruses, method for their production and their use as vaccines |
US6534631B1 (en) | 1998-07-15 | 2003-03-18 | Human Genome Sciences, Inc. | Secreted protein HT5GJ57 |
AU6518298A (en) * | 1997-03-28 | 1998-10-22 | Nippon Zeon Co., Ltd. | Novel dna vector and vaccines containing novel recombinant dna vectors as the active ingredient |
US20070014787A1 (en) | 1998-07-15 | 2007-01-18 | Human Genome Sciences, Inc. | 71 human secreted proteins |
US7091315B1 (en) | 1998-07-15 | 2006-08-15 | Human Genome Sciences, Inc. | Protein HDPBQ71 |
CA2333917A1 (en) * | 1998-07-15 | 2000-01-27 | Human Genome Sciences, Inc. | 71 human secreted proteins |
US6872811B1 (en) * | 1998-09-30 | 2005-03-29 | Millennium Pharmaceuticals, Inc. | HRPCa9 and HRPCa10 nucleic acids and polypeptides |
US8623379B2 (en) | 2000-03-02 | 2014-01-07 | Emory University | Compositions and methods for generating an immune response |
WO2001092470A2 (en) | 2000-03-02 | 2001-12-06 | Emory University | Dna expression vectors and methods of use |
AU4594401A (en) | 2000-03-24 | 2001-10-08 | Calydon Inc | Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising uroplakin-specific transcriptional regulatory sequences, and methods of use thereof |
GB0014288D0 (en) * | 2000-06-10 | 2000-08-02 | Smithkline Beecham Biolog | Vaccine |
AU2001283042A1 (en) * | 2000-07-29 | 2002-02-13 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the il12b gene |
US7371554B2 (en) * | 2000-09-04 | 2008-05-13 | House Foods Corporation | Isozymes of lacrimator component synthase and gene encoding the same |
KR20030085528A (ko) * | 2001-02-07 | 2003-11-05 | 앵스띠뛰 파스퇴르 | 포토랍두스 루미네센스 균주 tt01 게놈 및 그 용도 |
AU2002252199B2 (en) | 2001-03-08 | 2008-01-03 | Emory University | MVA expressing modified HIV envelope, GAG, and POL genes |
WO2002100250A2 (en) * | 2001-06-12 | 2002-12-19 | The Regents Of The University Of California | Wit 3.0, a novel gene to control soft tissue wound healing |
JP4895505B2 (ja) | 2002-05-16 | 2012-03-14 | バヴァリアン・ノルディック・アクティーゼルスカブ | 変異ワクシニアウイルスアンカラ(mva)ゲノム中の挿入部位としての遺伝子間領域 |
US7056733B2 (en) * | 2003-02-19 | 2006-06-06 | University Of Kentucky Research Foundation | Nucleic acids encoding Sarcocystis neurona antigen and uses thereof |
JP5052893B2 (ja) * | 2003-02-20 | 2012-10-17 | アメリカ合衆国 | ポックスベクターにおける新規の挿入部位 |
GB0326798D0 (en) | 2003-11-17 | 2003-12-24 | Crusade Lab Ltd | Methods for generating mutant virus |
JP2007511216A (ja) | 2003-11-17 | 2007-05-10 | クルセイド ラボラトリーズ リミテッド | 変異ウイルス |
US7897146B2 (en) | 2003-11-17 | 2011-03-01 | Crusade Laboratories Limited | Treatment using herpes simplex virus |
JP4271122B2 (ja) * | 2004-10-15 | 2009-06-03 | 財団法人 ひろしま産業振興機構 | カイコでの組換えタンパク質製造のためのポリヌクレオチド |
US20060090646A1 (en) * | 2004-11-04 | 2006-05-04 | Questair Technologies Inc. | Adsorbent material for selective adsorption of carbon monoxide and unsaturated hydrocarbons |
US7807180B2 (en) * | 2007-08-21 | 2010-10-05 | University Of Massachusetts | Poxvirus methods and compositions |
US8314228B2 (en) * | 2009-02-13 | 2012-11-20 | Aurora Algae, Inc. | Bidirectional promoters in Nannochloropsis |
WO2011041790A1 (en) | 2009-10-02 | 2011-04-07 | The Trustees Of Columbia University In The City Of New York | Piscine reovirus diagnostic compositions |
AP2013007166A0 (en) | 2011-04-06 | 2013-10-31 | Univ Paris Descartes Inst De Rech Pour Le Dev Ird | Pharmaceutical compositions for preventing and/or treating an HIV disease in humans |
CA2875072C (en) * | 2012-06-01 | 2016-10-18 | Exxonmobil Research And Engineering Company | Promoters and terminators for use in eukaryotic cells |
US10612034B2 (en) | 2012-06-01 | 2020-04-07 | Exxonmobil Research And Engineering Company | Promoters and terminators for use in eukaryotic cells |
WO2014088560A1 (en) * | 2012-12-04 | 2014-06-12 | Exxonmobil Research And Engineering Company | Tetraselmis promoters and terminators for use in eukaryotic cells |
BR112018002172A8 (pt) * | 2015-07-31 | 2024-02-15 | Bavarian Nordic As | Promotores para intensificar a expressão em poxvírus |
ES2944314T3 (es) | 2016-01-08 | 2023-06-20 | Geovax Inc | Composiciones y procedimientos para generar una respuesta inmunitaria frente a un antígeno asociado a un tumor |
US11311612B2 (en) | 2017-09-19 | 2022-04-26 | Geovax, Inc. | Compositions and methods for generating an immune response to treat or prevent malaria |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5338683A (en) * | 1981-12-24 | 1994-08-16 | Health Research Incorporated | Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins |
US5174993A (en) * | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
WO1985005376A1 (fr) * | 1984-05-22 | 1985-12-05 | Transgene S.A. | Vecteurs d'expression du facteur ix et lignees cellulaires produisant le facteur ix actif |
EP0218625B1 (en) * | 1985-03-29 | 1995-04-05 | Btg International Limited | Infectious bronchitis virus spike protein |
US4713004A (en) * | 1986-09-04 | 1987-12-15 | Vent Plant Corporation | Submergible screw-type dental implant and method of utilization |
WO1988002022A1 (en) * | 1986-09-22 | 1988-03-24 | Commonwealth Scientific And Industrial Research Or | Recombinant poxviruses |
EP0284416B1 (en) * | 1987-03-27 | 1995-02-22 | Nippon Zeon Co., Ltd. | Recombinant avipoxyvirus |
DE10399032I1 (de) * | 1987-08-28 | 2004-01-29 | Health Research Inc | Rekombinante Viren. |
CA1340203C (en) * | 1987-09-16 | 1998-12-15 | Noboru Yanagida | Recombinant apivoxvirus |
FR2632863B2 (fr) * | 1987-10-29 | 1990-08-31 | Transgene Sa | Virus du fowlpox recombinant et vaccins derives de ces virus |
DE3813093A1 (de) * | 1988-04-19 | 1989-11-09 | Immuno Ag | Rekombinantes plasmid, verfahren zum herstellen eines rekombinanten avipoxvirus, rekombinantes avipoxvirus und dessen verwendung |
EP0353851B1 (en) * | 1988-06-24 | 1994-01-19 | Btg International Limited | Fowlpox virus non-essential regions |
US5093258A (en) * | 1988-08-26 | 1992-03-03 | Therion Biologics Corporation | Recombinant fowlpox virus and recombination vector |
CA2001001A1 (en) * | 1988-10-21 | 1990-04-21 | Matthew M. Binns | Fowlpox virus promoter |
-
1991
- 1991-08-26 DE DE69133333T patent/DE69133333T2/de not_active Expired - Fee Related
- 1991-08-26 DK DK91114300T patent/DK0538496T3/da active
- 1991-08-26 ES ES91114300T patent/ES2212795T3/es not_active Expired - Lifetime
- 1991-08-26 EP EP91114300A patent/EP0538496B1/en not_active Expired - Lifetime
- 1991-08-26 AT AT91114300T patent/ATE253123T1/de not_active IP Right Cessation
- 1991-08-26 EP EP03018689A patent/EP1380651A2/en not_active Withdrawn
-
1992
- 1992-07-10 AU AU19580/92A patent/AU661488B2/en not_active Ceased
- 1992-08-26 SK SK2640-92A patent/SK264092A3/sk unknown
- 1992-08-26 JP JP4227349A patent/JP2703853B2/ja not_active Expired - Fee Related
- 1992-08-26 CZ CS922640A patent/CZ264092A3/cs unknown
- 1992-08-26 CA CA002076903A patent/CA2076903A1/en not_active Abandoned
- 1992-08-26 HU HU9202753A patent/HU9202753D0/hu unknown
-
1994
- 1994-04-22 US US08/232,463 patent/US5670367A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HUT62653A (en) | 1993-05-28 |
JPH05192165A (ja) | 1993-08-03 |
EP1380651A2 (en) | 2004-01-14 |
CZ264092A3 (en) | 1993-03-17 |
ES2212795T3 (es) | 2004-08-01 |
ATE253123T1 (de) | 2003-11-15 |
SK264092A3 (en) | 1995-07-11 |
US5670367A (en) | 1997-09-23 |
AU661488B2 (en) | 1995-07-27 |
DE69133333T2 (de) | 2004-07-29 |
EP0538496A1 (en) | 1993-04-28 |
HU9202753D0 (en) | 1993-05-28 |
JP2703853B2 (ja) | 1998-01-26 |
AU1958092A (en) | 1993-03-04 |
DE69133333D1 (de) | 2003-12-04 |
EP0538496B1 (en) | 2003-10-29 |
CA2076903A1 (en) | 1993-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0538496T3 (da) | Rekombinant fjerkrækoppevirus med intakt FPV tk-gen | |
FI107610B (fi) | HCV-fuusioproteiini | |
DE3586520T2 (de) | Herpes simplex-virus als vektor. | |
ES2184735T3 (es) | Peptidos y secuencias de acido nucleico asociados con el virus epstein barr. | |
DK0707071T3 (da) | Rekombinante vektorer afledt fra adenovirus til anvendelse i genterapi | |
DE69535359D1 (de) | Rekombinantes herpesvirus aus trufhähnen und seine verwendungen | |
ES2137931T3 (es) | Proteinas gdf-1 y uog-1. | |
ATE284954T1 (de) | Hyaluronan synthase gen und seine verwendung | |
ATE73348T1 (de) | Thymidinkinase-deletionsmutanten von bovinem herpesvirus-1, diese enthaltende impfstoffe gegen bovine rhinotracheitis und verfahren zu deren herstellung und verwendung. | |
DE69214146T2 (de) | Deletionsmutanten von bovinem herpuvirus-1, auf diese basierte impfstoffe,diagnosesätze für den nachweis von bovinem herpesvirus-1 | |
MX9202512A (es) | Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus. | |
ATE233821T1 (de) | Poxvirusvektoren und deren anwendung als impstoff gegen katzenansteckende peritonitis- viruskrankheit | |
ATE243755T1 (de) | Rekombinente adenoviren-impfstoffe | |
DE3852870T2 (de) | Saurer Fibroblast-Wachstumsfaktor-Mutant. | |
ES2061850T3 (es) | Virus recombinante de la enfermedad de marek, su procedimiento de preparacion y vacuna. | |
DK498387A (da) | Virus-dna-sekvens | |
WO1995005460A3 (en) | Feline immunodeficiency virus isolate ncsu 1 | |
KR880000579A (ko) | 베리셀라-죠스터 바이러스의 생산방법 | |
Landolfi et al. | Molecular weight diversity among murine class I antigens: both the mature cell surface forms and the unglycosylated polypeptides vary significantly in molecular weight | |
PT782628E (pt) | Melhoramento de um vector de expressao para a producao de proteinas recombinantes | |
SU1380209A1 (ru) | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ | |
DE60129607D1 (en) | Dna-fpr-expression von alpha-i-antitrypsin in methylotropher hefe | |
RU93018105A (ru) | Штамм рекомбинантного вируса осповакцины, вызывающий иммунитет против вируса венесуэльского энцефаломиелита лошадей в организме животных, и способ его получения | |
TH50184A3 (th) | วิธีสำหรับการเพาะเลี้ยงขนาดใหญ่ของเซลล์ที่ผลิตรีคอมบิแนนท์อิริโธรพอยอิทินของมนุษย์ | |
NO941544L (no) | Rekombinant kjerne-streptavidin |